Back to Agenda
Adaptive Approaches and Patient Access - Pushing Payer Boundaries or Facilitating New Payment Models?
Session Chair(s)
Solange Corriol-Rohou, DrMed, MD, PhD
Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
AstraZeneca , France
Adaptive pathways should enable patients’ earlier access to promising treatments in areas of high unmet medical need. This is certainly a sensitive and controversial concept which value needs to be supported by scientific evidence. What evidence should be generated, which tools and methods could enable MAPPs, or are missing and thus need development? What criteria would need to be fulfilled for products to be eligible to enter such pathways? In addition, implications of such pathways for access decisions at the national or regional levels remain to be explored. How HTA bodies, payers and manufacturers will deal with product value uncertainty and how this may affect solutions in the form of managed-entry agreements? These are questions that will be addressed by ADAPT SMART consortium members.
Learning Objective : While exploring the MAPPs (Medicines Adaptive Pathways to Patients) concept, the session will be the opportunity to understand how the IMI ADAPT SMART consortium has established an enabling platform and engaged a dialogue with all relevant stakeholders for the coordination of MAPPs related activities.
Speaker(s)
Scientific Drivers of Progress – Gaps and Opportunities
Solange Corriol-Rohou, DrMed, MD, PhD
AstraZeneca , France
Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
MAPPs Engagement Criteria – Patient Perspective
Mathieu Boudes, PhD
Montsouris Consilium, France
Patient Engagement Director
Pushing Payer Boundaries or Facilitating New Payment Models?
Jacoline Bouvy, PhD
National Institute for Health and Care Excellence (NICE), United Kingdom
Scientific Adviser, Science Policy and Research Programme
Have an account?